Abstract Details

Title Initial Experience with the Coaxial Dual Lumen Scepter C Balloon Catheter for Endovascular Management of Cerebral Vasospasm from Subarachnoid Hemorrhage

Topic Interventional Neurology

Presentation(s) P04 - (-)

Poster/Presentation
Number 088

Objective

Background BACKGROUND: Post-hemorrhagic cerebral vasospasm accounts for the majority of morbidity/mortality in patients with subarachnoid hemorrhage (SAH) and is related to the development of delayed cerebral ischemia and infarction. Intra-arterial vasodilators and/or balloon angioplasty are used when medical management fails.

Design/Methods DESIGN/METHODS: The neuroendovascular database of two tertiary-care hospitals was searched to identify all patients for whom the Scepter C catheter was used for treatment of SAH-related cerebral vasospasm. Patient demographics, clinical characteristics and procedural data were obtained by retrospective chart review.

Results RESULTS: Seven patients (6 female), with mean age 44 (range 40-50 years) were included in the study. Ruptured aneurysms were located in the anterior communicating (3 patients), posterior communicating (1), basilar apex (1), middle cerebral (1) and posterior inferior cerebellar (1) arteries. Medically-refractory vasospasm developed 7-22 days post-bleed and was treated with the Scepter C catheter using intra-arterial vasodilators and angioplasty. Fluoroscopy times ranged from 12.5-27.3 minutes. There were no complications, or large-vessel vasospasm recurrence post-procedure requiring repeat intra-arterial therapy.

Conclusions CONCLUSIONS: The Scepter C has many advantages, making it an extremely useful device. Its inner lumen has a diameter of 0.0165", permitting the use of standard 0.014" microwires providing additional guidewire support for vessel selection, thereby reducing the frequency of wire-exchanges. It also allows for removal of the wire to reshape or switch to a different microwire while leaving the balloon catheter in place, allowing for multiple inflations during angioplasty. The balloon is inflated using the outside lumen without the need for an obstructing microwire and there is no retrograde filling of blood into the balloon lumen. Initial experience using Scepter C demonstrates its feasibility in the treatment of cerebral vasospasm.

Authors/Disclosures
Dimitrios A. Nacopoulos, MD PRESENTER	No disclosure on file
Seby John, MD (Cleveland Clinic Abu Dhabi)	Dr. John has nothing to disclose.
	No disclosure on file
	No disclosure on file
Mark Hallett, MD, FAAN (National Institutes of Health)	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��